<qa>  What is the primary objective of the study?The primary objective is to compare the mean changes of HbA1c at week 26 between the two groups, SU glimepiride administration and TZDs Pioglitazone administration, as the third-order drug among patients whose treatment is not sufficient after the combined administration of Metformin and Alogliptin. 